# Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock

> **NCT05800951** · — · ACTIVE_NOT_RECRUITING · sponsor: **Henry Ford Health System** · enrollment: 124 (actual)

## Conditions studied

- Cardiogenic Shock
- Acute Myocardial Infarction
- STEMI - ST Elevation Myocardial Infarction
- NSTEMI - Non-ST Segment Elevation MI
- STEMI
- NSTEMI
- Acute Myocardial Infarction of Right Ventricle (Disorder)
- Acute Myocardial Infarction of Left Ventricle
- Acute Myocardial Infarction With ST Elevation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05800951
- **Lead sponsor:** Henry Ford Health System
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-07-22
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2026-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05800951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05800951, "Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05800951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*